These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1329 related articles for article (PubMed ID: 24248382)

  • 21. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration.
    Lagier-Tourenne C; Baughn M; Rigo F; Sun S; Liu P; Li HR; Jiang J; Watt AT; Chun S; Katz M; Qiu J; Sun Y; Ling SC; Zhu Q; Polymenidou M; Drenner K; Artates JW; McAlonis-Downes M; Markmiller S; Hutt KR; Pizzo DP; Cady J; Harms MB; Baloh RH; Vandenberg SR; Yeo GW; Fu XD; Bennett CF; Cleveland DW; Ravits J
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):E4530-9. PubMed ID: 24170860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zfp106 binds to G-quadruplex RNAs and inhibits RAN translation and formation of RNA foci caused by G4C2 repeats.
    Celona B; Salomonsson SE; Wu H; Dang B; Kratochvil HT; Clelland CD; DeGrado WF; Black BL
    Proc Natl Acad Sci U S A; 2024 Jul; 121(31):e2220020121. PubMed ID: 39042693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA-mediated toxicity in C9orf72 ALS and FTD.
    McEachin ZT; Parameswaran J; Raj N; Bassell GJ; Jiang J
    Neurobiol Dis; 2020 Nov; 145():105055. PubMed ID: 32829028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-depth clinico-pathological examination of RNA foci in a large cohort of C9ORF72 expansion carriers.
    DeJesus-Hernandez M; Finch NA; Wang X; Gendron TF; Bieniek KF; Heckman MG; Vasilevich A; Murray ME; Rousseau L; Weesner R; Lucido A; Parsons M; Chew J; Josephs KA; Parisi JE; Knopman DS; Petersen RC; Boeve BF; Graff-Radford NR; de Boer J; Asmann YW; Petrucelli L; Boylan KB; Dickson DW; van Blitterswijk M; Rademakers R
    Acta Neuropathol; 2017 Aug; 134(2):255-269. PubMed ID: 28508101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antisense, but not sense, repeat expanded RNAs activate PKR/eIF2α-dependent ISR in
    Parameswaran J; Zhang N; Braems E; Tilahun K; Pant DC; Yin K; Asress S; Heeren K; Banerjee A; Davis E; Schwartz SL; Conn GL; Bassell GJ; Van Den Bosch L; Jiang J
    Elife; 2023 Apr; 12():. PubMed ID: 37073950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy.
    Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L
    Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FUS regulates RAN translation through modulating the G-quadruplex structure of GGGGCC repeat RNA in
    Fujino Y; Ueyama M; Ishiguro T; Ozawa D; Ito H; Sugiki T; Murata A; Ishiguro A; Gendron T; Mori K; Tokuda E; Taminato T; Konno T; Koyama A; Kawabe Y; Takeuchi T; Furukawa Y; Fujiwara T; Ikeda M; Mizuno T; Mochizuki H; Mizusawa H; Wada K; Ishikawa K; Onodera O; Nakatani K; Petrucelli L; Taguchi H; Nagai Y
    Elife; 2023 Jul; 12():. PubMed ID: 37461319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis.
    Saberi S; Stauffer JE; Jiang J; Garcia SD; Taylor AE; Schulte D; Ohkubo T; Schloffman CL; Maldonado M; Baughn M; Rodriguez MJ; Pizzo D; Cleveland D; Ravits J
    Acta Neuropathol; 2018 Mar; 135(3):459-474. PubMed ID: 29196813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins.
    Mori K; Arzberger T; Grässer FA; Gijselinck I; May S; Rentzsch K; Weng SM; Schludi MH; van der Zee J; Cruts M; Van Broeckhoven C; Kremmer E; Kretzschmar HA; Haass C; Edbauer D
    Acta Neuropathol; 2013 Dec; 126(6):881-93. PubMed ID: 24132570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose hypometabolism prompts RAN translation and exacerbates C9orf72-related ALS/FTD phenotypes.
    Nelson AT; Cicardi ME; Markandaiah SS; Han JY; Philp NJ; Welebob E; Haeusler AR; Pasinelli P; Manfredi G; Kawamata H; Trotti D
    EMBO Rep; 2024 May; 25(5):2479-2510. PubMed ID: 38684907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p.
    Stewart H; Rutherford NJ; Briemberg H; Krieger C; Cashman N; Fabros M; Baker M; Fok A; DeJesus-Hernandez M; Eisen A; Rademakers R; Mackenzie IR
    Acta Neuropathol; 2012 Mar; 123(3):409-17. PubMed ID: 22228244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of toxicity in C9FTLD/ALS.
    Gendron TF; Belzil VV; Zhang YJ; Petrucelli L
    Acta Neuropathol; 2014 Mar; 127(3):359-76. PubMed ID: 24394885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD.
    Liu Y; Pattamatta A; Zu T; Reid T; Bardhi O; Borchelt DR; Yachnis AT; Ranum LP
    Neuron; 2016 May; 90(3):521-34. PubMed ID: 27112499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DDX3X overexpression decreases dipeptide repeat proteins in a mouse model of C9ORF72-ALS/FTD.
    Fu X; Zhang Z; Hayes LR; Wright N; Asbury J; Li S; Ye Y; Sun S
    Exp Neurol; 2024 Jun; 376():114768. PubMed ID: 38556190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.
    Dobson-Stone C; Hallupp M; Bartley L; Shepherd CE; Halliday GM; Schofield PR; Hodges JR; Kwok JB
    Neurology; 2012 Sep; 79(10):995-1001. PubMed ID: 22875086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
    Zhang K; Grima JC; Rothstein JD; Lloyd TE
    Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.
    DeJesus-Hernandez M; Mackenzie IR; Boeve BF; Boxer AL; Baker M; Rutherford NJ; Nicholson AM; Finch NA; Flynn H; Adamson J; Kouri N; Wojtas A; Sengdy P; Hsiung GY; Karydas A; Seeley WW; Josephs KA; Coppola G; Geschwind DH; Wszolek ZK; Feldman H; Knopman DS; Petersen RC; Miller BL; Dickson DW; Boylan KB; Graff-Radford NR; Rademakers R
    Neuron; 2011 Oct; 72(2):245-56. PubMed ID: 21944778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic reduction of GGGGCC repeat RNA levels by hnRNPA3 suppresses neurodegeneration in Drosophila models of C9orf72-linked ALS/FTD.
    Taminato T; Takeuchi T; Ueyama M; Mori K; Ikeda M; Mochizuki H; Nagai Y
    Hum Mol Genet; 2023 May; 32(10):1673-1682. PubMed ID: 36611007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G
    Rothstein JD; Baskerville V; Rapuri S; Mehlhop E; Jafar-Nejad P; Rigo F; Bennett F; Mizielinska S; Isaacs A; Coyne AN
    Acta Neuropathol; 2023 Nov; 147(1):1. PubMed ID: 38019311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.